5.02
price down icon2.90%   -0.15
after-market After Hours: 5.01 -0.010 -0.20%
loading
Xeris Biopharma Holdings Inc stock is traded at $5.02, with a volume of 1.08M. It is down -2.90% in the last 24 hours and up +6.58% over the past month. Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
See More
Previous Close:
$5.17
Open:
$5.18
24h Volume:
1.08M
Relative Volume:
0.52
Market Cap:
$785.05M
Revenue:
$181.41M
Net Income/Loss:
$-59.56M
P/E Ratio:
-11.95
EPS:
-0.42
Net Cash Flow:
$-38.83M
1W Performance:
-1.76%
1M Performance:
+6.58%
6M Performance:
+45.51%
1Y Performance:
+96.48%
1-Day Range:
Value
$4.99
$5.18
1-Week Range:
Value
$4.99
$5.235
52-Week Range:
Value
$2.095
$6.07

Xeris Biopharma Holdings Inc Stock (XERS) Company Profile

Name
Name
Xeris Biopharma Holdings Inc
Name
Phone
844-445-5704
Name
Address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Name
Employee
394
Name
Twitter
@XerisPharma
Name
Next Earnings Date
2024-12-08
Name
Latest SEC Filings
Name
XERS's Discussions on Twitter

Compare XERS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XERS
Xeris Biopharma Holdings Inc
5.02 828.00M 181.41M -59.56M -38.83M -0.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-11-24 Downgrade Piper Sandler Overweight → Neutral
Mar-28-24 Initiated Oppenheimer Outperform
Aug-28-23 Initiated Craig Hallum Buy
Oct-21-22 Initiated Jefferies Buy
Apr-28-22 Initiated Craig Hallum Buy
Nov-17-21 Initiated SVB Leerink Outperform
Oct-29-21 Initiated H.C. Wainwright Buy
Apr-07-21 Resumed RBC Capital Mkts Outperform
Feb-18-20 Initiated Piper Sandler Overweight
Jul-16-18 Initiated Jefferies Buy
Jul-16-18 Initiated Leerink Partners Outperform
Jul-16-18 Initiated RBC Capital Mkts Outperform
View All

Xeris Biopharma Holdings Inc Stock (XERS) Latest News

pulisher
04:39 AM

Cwm LLC Increases Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

04:39 AM
pulisher
Jul 25, 2025

Is Xeris Biopharma Holdings Inc. a good long term investmentDouble or triple returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Xeris Biopharma Holdings Inc. stock split in the near futureGame-changing capital returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Xeris Biopharma Holdings Inc. stockFree Trend-Following Techniques - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Xeris Biopharma Holdings Inc. Stock Analysis and ForecastExplosive capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Xeris Biopharma Holdings Inc. stock pricePowerful profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Xeris Biopharma Holdings Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Xponance Inc. Invests $57,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 21, 2025
pulisher
Jul 16, 2025

how xeris biopharma holdings inc. stock performs during market volatilityMarket Timing Advice - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

why xeris biopharma holdings inc. stock attracts strong analyst attentionMassive Upside Selection - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Brown Advisory Inc. Has $630,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

Why Xeris Biopharma Holdings Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xeris Biopharma Holdings Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

A Piece Of The Puzzle Missing From Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) 25% Share Price Climb - simplywall.st

Jul 15, 2025
pulisher
Jul 14, 2025

Xeris Biopharma's 7% Spike: Unraveling the Mysterious Move - AInvest

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Has $172,000 Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Xeris Biopharma's 10% Spike: A Technical and Market Flow Deep Dive - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Xeris Biopharma (NASDAQ:XERS) versus Mangoceuticals (NASDAQ:MGRX) Head to Head Review - Defense World

Jul 08, 2025
pulisher
Jun 28, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 28, 2025
pulisher
Jun 20, 2025

Rhumbline Advisers Increases Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

Wealth Enhancement Advisory Services LLC Raises Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Up 8.4% Following Insider Buying Activity - Defense World

Jun 18, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Acquires New Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 15, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Has $138,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Leerink Partnrs Estimates Xeris Biopharma FY2025 Earnings - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Leerink Partnrs Forecasts Lower Earnings for Xeris Biopharma - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Down 5.5%Should You Sell? - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Leerink Partners raises Xeris Pharmaceuticals stock price target By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : Xeris Biopharma Holdings, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - MarketScreener

Jun 05, 2025
pulisher
Jun 04, 2025

Xeris at Jefferies Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

xeris biopharma holds annual meeting, elects directors By Investing.com - Investing.com South Africa

Jun 04, 2025

Xeris Biopharma Holdings Inc Stock (XERS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):